Dr. Lloyd Damon, MD

Dr. Damon practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Damon's NPI, 1548224058, was assigned on April 12, 2006. Dr. Damon graduated from University Of Michigan Medical School in 1982. Dr. Damon holds California license G51715.

Dr. Damon's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Damon's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Damon to 3 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Damon practices, 4 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Damon's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Damon is board certified in hematology by the American Board of Internal Medicine. Dr. Damon is licensed in California.

Dmand AI lists chronic anemia, chronic leukemia, deep vein thrombosis (DVT), immune deficiency disease, lung cancer, lymphoma, multiple myeloma and neutropenia among the conditions Dr. Damon treats.

CMS data shows 698 Medicare services from Dr. Damon across 8 procedure codes in 2024, for 278 Medicare patients. Medicare paid $43,889 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 278 Medicare patients who saw Dr. Damon in 2024. The largest group is 65 to 74, with 117 patients. 70% of them have high blood pressure, and 66% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Damon's median patient age at 71, with 52% women.

In 2024, Dr. Damon wrote 706 Medicare Part D claims for 95 patients. 50% of them were for generic drugs. CMS names the drug for 451 of them, across 19 drugs with 11 or more claims each, at $4,320,111 in total drug cost. In 2023, CMS named 768 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Damon for performance year 2024, reported as part of a group. Dr. Damon accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Damon as offering telehealth.

Dmand AI links 105 papers to Dr. Damon, published from 2002 to 2025. 2019 was the busiest year, with 7. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Hematopoietic Stem Cell Transplantation and Transplantation, Autologous. Dr. Damon has published most often in Bone Marrow Transplant. Dr. Damon's most frequent co-authors are Rebecca L. Olin, MD, Gabriel Noah Mannis, MD and Thomas G. Martin, MD.

Dmand AI links Dr. Damon to 7 clinical trials, 4 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Leukemia, Myeloid, Acute, Leukemia, Myeloid and Lymphoma, Mantle-Cell. Jonsson Comprehensive Cancer Center sponsors the most, 2.

CMS Open Payments shows 32 general payments to Dr. Damon from 12 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 67% of the total. Jazz Pharmaceuticals Inc. paid the most, $5,985.

Dmand AI lists 5 awards for Dr. Damon, most recently America's Top Doctors in 2014.

Dr. Damon graduated from University Of Michigan Medical School in 1982.

Dr. Damon is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.